Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
694 ensayos encontrados
Completado
Fase 4
ClinicalTrials.gov
A 5-year Study to Compare the Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-naïve Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 30 de mar de 2012
ID: NCT01528254
Completado
ClinicalTrials.gov
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Recombinant Human Parathyroid Hormone, PTH (Forteo)
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00365924
Completado
Fase 3
ClinicalTrials.gov
A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00960661
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
INTERVENTIONAL
Inicio: 18 de nov de 2019
ID: NCT04109066
Completado
Fase 3
ClinicalTrials.gov
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
INTERVENTIONAL
Inicio: 10 de ene de 2004
ID: NCT00172172
Completado
ClinicalTrials.gov
A Non-interventional Cross-sectional Study to Capture the Prevalence of Cardiovascular Disease in Patients With Type 2 Diabetes - an International Observation
OBSERVATIONAL
Inicio: 10 de dic de 2018
ID: NCT03811288
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00549757
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Open-label Phase II Multicenter Study Evaluating the Efficacy of Oral Everolimus Alone or in Combination With Pasireotide LAR i.m. in Advanced Progressive Pancreatic Neuroendocrine Tumors (PNET) - The COOPERATE-2 Study
INTERVENTIONAL
Inicio: 1 de jun de 2011
ID: NCT01374451
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01106677
Completado
Fase 3
ClinicalTrials.gov
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de nov de 2008
ID: NCT00676338
Completado
Fase 3
ClinicalTrials.gov
Liraglutide Effect and Action in Diabetes (LEAD-1): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride Versus Glimepiride Monotherapy Versus Glimepiride and Rosiglitazone Combination Therapy in Subjects With Type 2 Diabetes.
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00318422
Completado
Fase 4
ClinicalTrials.gov
The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine When Added to Existing Oral Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00279201
Completado
Fase 3
ClinicalTrials.gov
SELECT - Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
INTERVENTIONAL
Inicio: 24 de oct de 2018
ID: NCT03574597
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00106808
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
INTERVENTIONAL
Inicio: 14 de jul de 2017
ID: NCT03214380
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00663260
Completado
Fase 4
ClinicalTrials.gov
Comparison of the Hemodynamic Changes in Patients Under Treatment With Bisoprolol Versus Atenolol
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01939509
Completado
Fase 3
ClinicalTrials.gov
A Phase III Trial to Compare the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus an Aromatase Inhibitor (AI) vs. Trastuzumab Plus an AI vs. Lapatinib Plus an AI as 1st- or 2nd- Line Therapy in Postmenopausal Subjects With Hormone Receptor+, HER2-positive Metastatic Breast Cancer (MBC) Who Received Prior Trastuzumab and Endocrine Therapies
INTERVENTIONAL
Inicio: 5 de may de 2011
ID: NCT01160211
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind Clinical Trial to Evaluate the Safety and Tolerability of 24 Weeks Treatment With (50 mg qd) Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00646542
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
INTERVENTIONAL
Inicio: 29 de may de 2019
ID: NCT03952130
Anterior
1
...
21
22
23
...
35
Siguiente
Filtros